Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
CONCLUSIONS: In conclusion, the results of the current study indicate that HOXC6 promotes glioma U87 cell growth through the WIF-1/Wnt signaling pathway and HOXC6 might be a novel target in clinical treatment for gliomas.
PMID: 30228024 [PubMed - as supplied by publisher]
Source: Pathology, Research and Practice - Category: Pathology Authors: Yan TF, Wu MJ, Xiao B, Hu Q, Fan YH, Zhu XG Tags: Pathol Res Pract Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Glioma | Neurology | Pathology | Science | Study